1. Home
  2. RANI vs CAAS Comparison

RANI vs CAAS Comparison

Compare RANI & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$0.95

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

CAAS

China Automotive Systems Inc.

HOLD

Current Price

$4.58

Market Cap

128.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RANI
CAAS
Founded
2012
N/A
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
126.8M
128.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
RANI
CAAS
Price
$0.95
$4.58
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
1.0M
39.9K
Earning Date
05-07-2026
04-22-2026
Dividend Yield
N/A
N/A
EPS Growth
57.14
N/A
EPS
N/A
N/A
Revenue
$1,633,000.00
N/A
Revenue This Year
$274.77
N/A
Revenue Next Year
$79.44
N/A
P/E Ratio
N/A
$3.97
Revenue Growth
58.85
N/A
52 Week Low
$0.39
$3.87
52 Week High
$3.87
$5.15

Technical Indicators

Market Signals
Indicator
RANI
CAAS
Relative Strength Index (RSI) 47.57 49.07
Support Level $0.86 $4.51
Resistance Level $1.10 $4.75
Average True Range (ATR) 0.09 0.17
MACD -0.01 -0.02
Stochastic Oscillator 28.23 13.04

Price Performance

Historical Comparison
RANI
CAAS

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: